Alexandria, Va, May 17, 2017 -- http://www.globenewswire.com/NewsRoom/AttachmentNg/8fa87936-d37e-4578-8d81-50b10f38bdc9
|
|||||
GlyphEd™, the leading provider of interactive data visualization and discovery technology for college and university Enrollment Management, announced today that Human Capital Research Corporation (HCRC) will integrate GlyphEd's GlyphBuilder™1.0 and GlyphViewer™ software into its analytic framework.
Human Capital Research Corporation provides strategic and tactical guidance to education policy makers, administrators and practitioners. Using an extensive array of statistical research methods reflecting multiple disciplines, HCRC offers a wide range of quantitatively-based research services that fall under the purview of enrollment management, curriculum innovation and institutional finance.
"We anticipate that the integration of GlyphEd™ into our research practices will provide deeper insights that will enhance our understanding of segmented behaviors with potential bearing on market development, yield prediction and student retention.”
GlyphEd's software allows non-technical users to define, design, create, and share easy to use visualizations of complex data. In a single graphical / visual representation (i.e., on one computer screen), GlyphEd™ presents data related to a variety of factors important to the Enrollment Management Office.
"GlyphEd™ improves the efficiency and effectiveness of Enrollment Management personnel - ultimately reducing the amount of time spent reviewing the breadth and depth of data needed to make decisions," said Mark Sloan, Founder and CEO of GlyphEd™. "We're thrilled to work with Human Capital Research Corporation. Both companies strive for the same positive outcomes for our clients and the students that they serve.
GlyphEd™ integrates with existing CRM and Enrollment Management data systems.
About GlyphEd™
GlyphEd™ is transforming the way Enrollment Management Offices interact with data for discovery and insight. It offers a new way to interact with data, discover insights, and make informed decisions. Ultimately, the GlyphEd™Enrollment Management GlyphKIT™ allows colleges and universities to make faster, more informed decisions across Marketing / Recruiting, Admissions, Financial Aid, and Retention (coming soon). Additionally, GlyphEd™ sits on top of existing IT investments in CRM and other data – allowing colleges and universities to get a greater return on IT investments.
For more information about GlyphEd, visit www.GlyphEd.co Contact us at: [email protected]
GlyphEd™ is a joint venture with SynGlyphX™ http://www.globenewswire.com/NewsRoom/AttachmentNg/8fa87936-d37e-4578-8d81-50b10f38bdc9
For more information about GlyphEd, visit www.GlyphEd.co Contact us at: [email protected] John Lang (571) 733-9471 [email protected]


Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Washington Post Publisher Will Lewis Steps Down After Layoffs
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Instagram Outage Disrupts Thousands of U.S. Users
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans 



